Key result
Randomization of 144 asymptomatic patients to home BP telemonitoring plus urinary peptidomic profiling versus telemonitoring alone demonstrated the feasibility of this multi-ethnic trial.
Why the study?
High blood pressure and type-2 diabetes lead to chronic kidney disease and left ventricular dysfunction, while home blood pressure telemonitoring and urinary peptidomic profiling may enable personalized prevention.
Population
144 randomized asymptomatic patients aged 55-75 years with ≥5 cardiovascular risk factors
Comparison
HTM plus UPP vs HTM alone
Design
Investigator-initiated multicenter open-label randomized trial with blinded endpoint evaluation
Authors
Loading...
Trial will test if adding UPP to HTM improves CV/renal outcomes; extends personalized prevention in high-risk hypertension and diabetes.
RCT (n=144)
Open-label
randomized
Yes
An et al. (2023) conducted an RCT in Cardiovascular risk factors (n=144). Home BP telemonitoring plus urinary peptidomic profiling vs. Home BP telemonitoring alone was evaluated on Efficacy in guiding treatment. Randomization of 144 asymptomatic patients to home BP telemonitoring plus urinary peptidomic profiling versus telemonitoring alone demonstrated the feasibility of this multi-ethnic trial.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: